Citations

Clear

1294 citation(s) found for "Kumar, Shaji".

Health-Related Quality of Life for Frail Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide and Dexamethasone: Subgroup Analysis of MAIA Trial
Plesner, Torben , Usmani, Saad Z. , Kumar, Shaji , Hulin, Cyrille , Roussel, Murielle , Delforge, Michel, Karlin, Lionel , Arnulf, Bertrand , Pei, Huiling , Gupta, Niodita, Kaila, Shuchita, Matt, Kathryn, Gries, Katharine S. , Carson, Robin, Borgsten, Fredrik, Usmani, Saad , Roussel, Murielle , Perrot, Aurore , Facon, Thierry T.F. , Bahlis, Nizar Jacques , Orlowski, Robert Z. , Nahi, Hareth , Mollee, Peter , Ramasamy, Karthik , Jaccard, Arnaud , Chari, Ajai , Weisel, Katja C

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1142-1145

10.1182/blood-2022-165524 Get It

A Multicenter Phase I Dose-Escalation Trial of a Novel Glutaminase Inhibitor Telaglenastat in Combination with Carfilzomib and Dexamethasone in Relapsed and Refractory Multiple Myeloma
Allred, Jacob B., Kumar, Shaji , Costello, Brian A. , Gonsalves, Wilson I. , Neparidze, Natalia , Reid, Joel M. , Shapiro, Geoffrey I. , Piekarz, Richard , Baz, Rachid , Devarakonda, Srinivas

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7315-7316

10.1182/blood-2022-164966 Get It

Myeloma Developing Regimens Using Genomics (MyDRUG): Longitudinal Single-Cell Transcriptional Landscape of the Myeloma and Immune Microenvironment in Relapsed/Refractory Multiple Myeloma Patients Treated with MEK-Inhibitor, Cobimetinib
Mulligan, George, Cook, April , Hamilton, Mark , Gnjatic, Sacha , Kumar, Shaji , Gnjatic, Sacha , Jayasinghe, Reyka G. , Cook, April, Kim-Schulze, Seunghee , Cho, Hearn Jay

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7090-7091

10.1182/blood-2022-167462 Get It

Optimal Sequencing Determination in Relapsed Multiple Myeloma
Sengsayadeth, Salyka, Fitzgerald, Bridget, Nandakumar, Bharat , Schmidt, Timothy M. , Silbermann, Rebecca , Chen, Heidi , Kumar, Shaji , Thapa, Bicky , Chhabra, Saurabh , Callander, Natalie S. , Costa, Luciano J.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10033-10035

10.1182/blood-2022-169589 Get It

A Simple Risk-Scoring Model for Estimating the Prognostic Impact of 1q Gain in Patients with Newly-Diagnosed Multiple Myeloma
Jin, Fengyan, Yang, Pei‐Yu , Chen, Haimin , Liang, Xinyue , Xu, Weiling , Yu, Shanshan , Yi, Xingchen, Tian, Mengru, Yue, Tingting , Yan, Yurong, Hu, Zhongli, Kumar, Shaji , Zhou, Fan , Jin, Fengyan , Huang, Wenyang , Guo, Qiang , Yue, Tingting, Li, Mengyao , Zhang, Yingjie , Zhang, Mengxue , Dai, Yun

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4360-4361

10.1182/blood-2022-168602 Get It

MonumenTAL-5: A Phase 3 Study of Talquetamab Versus Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Who Received ≥4 Prior Lines of Therapy, Including a Proteasome Inhibitor, an Immunomodulatory Drug, and an Anti-CD38 Monoclonal A
Kumar, Shaji , Trudel, Suzanne , Ma, Xuewen, Olyslager, Yunsi, Thakkar, Payal, Pei, Lixia, Heuck, Christoph, Garfall, Alfred L. , Ocio, Enrique M. , Scott, Emma , Huang, Lin , Terpos, Evangelos

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7292-7293

10.1182/blood-2022-163260 Get It